Accellix, Inc. is launching its Next Generation Integrated Accellix Instrument and Consumables to further automate, simplify and improve reproducibility during the intricate process of QC for cell therapy manufacturing. Accellix entered the cell therapy market in 2017, automating the complete flow cytometry workflow, from sample preparation to analysis, which is considered the golden standard in […]

Vienna, Austria – Lexogen GmbH, a Vienna based Next-Generation Sequencing (NGS) and transcriptomics company, receives funding from the Austria Research Promotion Agency (FFG) for the development of a novel SARS-CoV-2 test method for mass screening. The company has already developed and commercialized multiple methods for high throughput RNA analysis and will base the test on its QuantSeq-Flex Targeted […]

Warburg Pincus brings strong healthcare experience and a global network to support innovation and scale-up as Polyplus serves the gene and cell therapy market. Illkirch, FRANCE –– Polyplus-transfection® SA (“Polyplus”), a developer of innovative and cost-effective technology used in gene and cell therapy, closed on a major investment from Warburg Pincus, a leading global private equity firm […]

OXGENE™ and The Native Antigen Company (NAC) today announced a collaboration to accelerate production of SARS-CoV-2 (COVID-19) reagents by combining OXGENE’s proprietary Adenoviral Protein Machine technology with NAC’s antigen development expertise. Together, OXGENE™ and NAC will develop high purity proteins at scale for the urgently-needed development of diagnostics and vaccines. OXGENE™ and The Native Antigen […]

SAN DIEGO– Illumina, Inc. (NASDAQ: ILMN) is pleased to announce that the African Union Commission, on behalf of the Africa Center for Disease Control and Prevention (CDC), is receiving a $1.4 million donation of our sequencing systems and related consumables intended to expand SARS-CoV-2 sequencing capabilities and capacity in ten African countries, including the Democratic […]

SAN DIEGO, CALIFORNIA & ADDIS ABABA, ETHIOPIA. Illumina, Inc. has donated sequencing systems and related consumables to the African Union Commission through the Africa Centres for Disease Control and Prevention (Africa CDC) to strengthen SARS-CoV-2 sequencing capabilities and capacity in 10 African countries. The cargo arrived Addis Ababa, Ethiopia, last week and the equipment is being […]

IPSWICH, Mass. — New England Biolabs (NEB®) today announced a transition to a 100% recyclable alternative to expanded polystyrene (EPS) for shipment of most of its products. The new packaging was developed by TemperPack, a U.S. company that focuses on providing sustainable solutions for cold chain shipping. While fully recyclable, this new packaging maintains the proper shipping […]

CINCINNATI — Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today the launch of a novel enzyme master mix (Inhibitor Tolerant 1-step RT-qPCR Mix) that eliminates the need to use an RNA extraction kit prior to running the patient sample through a molecular assay.  By eliminating this step, total assay cost is lower and processing times for […]

SAN DIEGO — SciCrunch’s Antibody Registry announced this week that it has partnered with ChromoTek to assign unique identifiers (RRIDs) to ChromoTek’s line of Nanobody based immunoreagents and antibodies. The partnership increases the database of RRIDs available for bioscience researchers use considerably both companies say. “I am delighted that we can form this partnership with […]

SAN DIEGO – TriLink BioTechnologies®, a Maravai LifeSciences company and a leader in the production of nucleic acids for research, diagnostics and therapeutics applications, and Imperial College London, a public research university located in the United Kingdom, announced today that they have entered into a partnership in which TriLink will manufacture self-amplifying RNA (saRNA) for […]